Central Nervous System Neoplasms

Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

Pediatric Prospective Personalized Immune and Target Identification Trial

B7-H3.CD28Z.CART in CNS Neoplasms

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients

EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients

RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Mapping Draining Lymph Nodes in CNS Malignancies

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Biomarker Analysis of Central Nervous System Tumors

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma